PYFA Reports 11.8% Sales Growth in Q1 2026, Reinforces Focus on High-Value Products and Capacity Expansion
JAKARTA, June 3, 2026 – PT Pyridam Farma Tbk (IDX: PYFA) recorded positive performance in the first quarter of 2026
Pyridam Farma (PYFA) Announces Resignation of President Commissioner Robby Yulianto; New Board to be Unveiled at Upcoming AGM
JAKARTA, MAY 25, 2026 – PT Pyridam Farma Tbk (IDX: PYFA) has officially announced the resignation of Robby Yulianto from
Protect Your Body from Hantavirus: PYFA Medical Expert Shares Vitamin Recommendations to Boost Immunity
JAKARTA, May 21 2026 – Amid growing public concern over the spread of Hantavirus, PT Pyridam Farma Tbk (IDX: PYFA) is urging
Enhancing Employee Fitness and Solidarity, Pyridam Farma (PYFA) Presents HYROX Through the PYFA Health Sports Community
JAKARTA, May 16 2026 – PT Pyridam Farma Tbk (IDX: PYFA) has officially established the PYFA Health Sports Community as a tangible
EGMS Approves Rights Issue, PT Pyridam Farma Tbk (PYFA) Prepares for Strategic Investments and Aggressive Expansion
PT Pyridam Farma Tbk (IDX: PYFA) is executing its Capital Increase with Pre-emptive Rights II (PMHMETD II), commonly known as
PYFA Sets Record Net Sales of IDR 2.76 Trillion in Fiscal Year 2025, EBITDA Reaches IDR 203.7 Billion
JAKARTA, 7 April 2026 – PT Pyridam Farma Tbk (IDX: PYFA) recorded accelerated growth in the 2025 fiscal year with
PYFA Production Facility in Cianjur Officially Certified ISO 45001:2018, Strengthening Its International Standard Management System
CIANJUR, 16 March 2026 – In an effort to strengthen safe and sustainable operational practices, PT Pyridam Farma Tbk (PYFA) has reaffirmed
Four New Sterile Injection Production Facilities of Ethica Industri Farmasi Ready to Operate and Expand Market Reach
CIKARANG, March 3, 2026 – PT Ethica Industri Farmasi (“PT EIF”), a pharmaceutical company specializing in sterile injectable products and